"Designing Growth Strategies is in our DNA"

U.S. Injectable Cytotoxic Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Alkylating Drugs, Cytotoxic Antibodies, Antimetabolites, Plant Alkaloids, and Others), By Application (Oncology, Rheumatoid Arthritis, Multiple Sclerosis, and Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Country Forecast, 2023-2030

Last Updated: January 27, 2025 | Format: PDF | Report ID: FBI109024

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions & Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, U.S., 2022
    2. New Product Launches, By Key Players
    3. Key Industry Developments: Mergers, Acquisitions, and Partnerships
    4. Impact of COVID-19 on the U.S. Injectable Cytotoxic Drugs Market
  5. U.S. Injectable Cytotoxic Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Alkylating Drugs
      2. Cytotoxic Antibodies
      3. Antimetabolites
      4. Plant Alkaloids
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Rheumatoid Arthritis
      3. Multiple Sclerosis
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Johnson and Johnson Services Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Sanofi
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Eli Lilly and Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Bristol-Myers Squibb Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Corning Incorporated
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Pfizer, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Merck & Co. Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Amgen, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: U.S. Injectable Cytotoxic Drugs Market Revenue Breakdown (USD Billion, %), By Drug Class, 2022 & 2030

Figure 2: U.S. Injectable Cytotoxic Drugs Market Value Share (%), By Drug Class, 2022 & 2030

Figure 3: U.S. Injectable Cytotoxic Drugs Market Value Share (%), by Application, 2022 & 2030

Figure 4: U.S. Injectable Cytotoxic Drugs Market Value Share (%), By Distribution Channel, 2022 & 2030

Figure 5: U.S. Injectable Cytotoxic Drugs Market Share (%), By Company, 2022

Table 1: U.S. Injectable Cytotoxic Drugs Market Revenue (USD Billion) Forecast, By Drug Class, 2019–2030

Table 2: U.S. Injectable Cytotoxic Drugs Market Revenue (USD Billion) Forecast, by Application, 2019–2030

Table 3: U.S. Injectable Cytotoxic Drugs Market Revenue (USD Billion) Forecast, By Distribution Channel, 2019–2030

U.S. Injectable Cytotoxic Drugs Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase